> Phoenix-based Zila has sold its OTC Zilactrin brand of oral and lip care products to Blairex Laboratories for $10.3 million. Article
> The FDA has accepted San Diego-based Santarus' NDA for Zegerid. Release
> Callisto Pharmacecuticals has received the FDA's orphan drug status for its experimental Annamycin, a therapy for acute myeloid leukemia. Release
> Takeda is selling its share of a joint animal drug program to its partner, Schering-Plough. Story
> Exagen Diagnostics, which is commercializing IVD kits based on genomic markers for prognostic or predictive testing, raised $7 million in Series B financing. Release
And Finally... The William and Melinda Gates Foundation has selected 47 projects to share $437 million in grant money to develop new public health solutions for the world's poorest people. Article